| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.07 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.07 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.07 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.052 | 0.07 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | 0.2 | 0.08 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |